Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Longitudinal, Observational Study to Evaluate Neurodevelopmental Status in Pediatric Patients With Hunter Syndrome (MPS II)

NCT01822184 is registered in ClinicalTrials.gov with Shire as lead sponsor.

NCT NCT01822184
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01822184 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Longitudinal, Observational Study to Evaluate Neurodevelopmental Status in Pediatric Patients With Hunter Syndrome (MPS II)
Lead sponsor
Shire
Phase
Observational
Overall status
Completed
Start date
January 18, 2013
Completion date
October 5, 2016
Enrollment
100 (actual)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

hunter syndrome, mucopolysaccharidosis (mps)